GoSilico

GoSilico offers a disruptive simulation technology enabling the computer-guided development of production processes for biopharmaceutical drugs. The core product is the simulation software ChromX, that is sold as annual licenses. The software enables biopharmaceutical companies worldwide to skip up to 95% of the lab experiments during process development and to replace them by computer-simulation. Biopharmaceuticals such as antibodies or vaccines can reach the patient faster and at lower costs.